glp 1 chronic kidney disease Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Glucagon-Like Peptide-1 Receptor Agonists for

Under Patels leadership, Wellstar will build on a strong foundation by advancing clinical excellence, strengthening academic programs and elevating quality, safety and patient experience

It further reveals how current advances in triple agonists and oral formulations promise to further lower barriers to treatment and enhance therapeutic outcomes

The Wegovy pill oral semaglutide from Novo Nordisk became the first FDA-approved oral GLP-1 for obesity in December 2025

Marketed as Mounjaro for diabetes and Zepbound for weight management, tirzepatide has rapidly become one of the most prescribed medications in the diabetes and obesity space